EPO Patents = 1

Forward Citations = 0

Loading Chart...

7 inventors (with patents filed for the assignee):

Hyoung Jin Kim (1 out of 22 patents)

Eun Kyung Yoo (1 out of 5 patents)

Sang Kweon Jeon (1 out of 1 patent)

4. Mooyoung Seo (1 out of 1 patent)

5. Sae Yeon Lee (1 out of 1 patent)

6. Hye Kyung Chang (1 out of 1 patent)

7. Soon Ha Kim (1 out of 1 patent)

8. Keon-Il Im (2 patents)

9. Nayoun Kim (3 patents)

10. Jung Yeon Lim (6 patents)

11. Seok Goo Cho (4 patents)

12. Young Sun Nam (1 patent)

13. Eun Sol Lee (0 patent)

1 patent: Sort by Forward Citations

1. 12649730 - Crystalline forms of 5-[(1,1-dioxido-4-thiomorpholinyl)methyl]-2-phenyl-N-(tetrahydro-2H-pyran-4-yl)-1H-indol-7-amine (2026-06-09),

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

1 Patents

#1,945 in Seoul

#5,790 in South Korea

Seoul, South Korea

Mitoimmune Therapeutics Inc.

Forward Citations = 0

7 inventors:

Hyoung Jin Kim (1 out of 22 patents)

Eun Kyung Yoo (1 out of 5 patents)

Sang Kweon Jeon (1 out of 1 patent)

4. Mooyoung Seo (1 out of 1 patent)

5. Sae Yeon Lee (1 out of 1 patent)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Mitoimmune Therapeutics Inc.. Retrieved from https://idiyas.com/company/mitoimmune-therapeutics

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

1 patent (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]